{"name":"Kelonia Therapeutics, Inc.","slug":"kelonia-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOTVA1eFg5eWszTVhJdUN1bWJleEFyM2ZpV2VWN2VQTkRKdllSNTJybnJHVDNqS0p6dmhWTmZRSUwtb3EzTDR3cER6d0ZzV2J2eS1wQXJJSDFxM1BmdnhGUUhybElxTnVpWjVva3g0RmFBd1pBMURBUkttb3VhelVvNllaZ1l4SE1RbDM2Y3FKUzlSVWVqUm01UWtXWGQ?oc=5","date":"2025-11-05","type":"trial","source":"Endpoints News","summary":"Lilly partners with AI biologics company; Amgen ends gastric cancer study - Endpoints News","headline":"Lilly partners with AI biologics company; Amgen ends gastric cancer study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPQW9QQTVJanBHUmJuYVRCbEVPUFFLaHhpX3YxLUtjUkZTNFo3UUlyOTBxbVJFOS1aR2VMUEdROWFZbHFNcFZSWm55bERKMW8tTWprLWM2U2sxU0IteXpRTTJWQ0FQNmVfa3FhNUVhV1BrSDY1U3hmVlVqSENUWi0yQU5GR3BsdHlMRWUzU3pvNWhrRjhKQUlZcWhHYVlLMV8xMTdXYXR4dEFxSFlHWi0wdG1SM19wNFlWLXBxbzYxQktyU3VaRWc?oc=5","date":"2025-02-25","type":"pipeline","source":"BioSpace","summary":"Crescent Biopharma Strengthens Leadership Team with Appointment of Three Key Executives - BioSpace","headline":"Crescent Biopharma Strengthens Leadership Team with Appointment of Three Key Executives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPMF9YdHFndkRra0hVMGc2am5QU1hJclBHaHNZZV9xSmxJNXNzc0hRQVJ6RC1qbHZYemd2NlNjX1dKNW9kRDh6eEZKS0gwV1NhSDlrUW5UazRZd0hKcDBNMWpVYnAzejNzaW9ZanFkY1g0dHBDVmIxU28tS3ZlZk5Gc2JVU1BXNGktWjZLTEdxNzl0aGg3S19aa2VGNkxrV1hvU1hpR0J3VE1SUVI3bWppS28yUW5saFE?oc=5","date":"2025-02-12","type":"pipeline","source":"Fierce Pharma","summary":"Astellas shifts investment focus to later-stage opportunities amid reprioritization - Fierce Pharma","headline":"Astellas shifts investment focus to later-stage opportunities amid reprioritization","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBFdDY2c3NsRFdzY19UM2ZtUVdvWUh1TkpIeG5rUi1fQnZ4RmhiNklha3FoLVN5OE56NnRRSmdNdE8ySkZVMU9vUktrcVg4bS1PWUs4?oc=5","date":"2025-01-14","type":"pipeline","source":"FirstWord Pharma","summary":"Umoja's $100M raise signals growing appetite for next-gen CAR-Ts - FirstWord Pharma","headline":"Umoja's $100M raise signals growing appetite for next-gen CAR-Ts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxObU5HMktUZE5CenZGR3lBeTNNd29UTnNESmtFa2FaTTkxUW4xNTFhWlNOLTh2dHA1NEN5RWpJWXgwT01fSG9GdU5kbHlmWGF4empPS09HdzlrcVUtMVdUczJtcTRaNl9LdDIxWHYwTlliZWVjd1Nua2pPX2xnUnVtdWhSanBqeHB1RS02dWdtQkxsSlh0blNMN1J6RFlGYUUtcHpxS0JMN2I3ZFV0bGZsbVNsdERUSGM?oc=5","date":"2024-02-20","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies - Genetic Engineering and Biotechnology News","headline":"Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPQzg2WUZqblFxOUJxd3JDT1U3N3hGdF9ta19vQmtCaDhNQWdVZzR2RTdvdU5DZlFVdTBhX2toR1JmdTB4Z0dORlQ2bHIyZFlZU1M4a3hiX1ZxVnhxNl81RU5KT2MzMGNST3NHWFlQdzREUTlOc2ZaV3k2dVp4a181cnBmREpfVThMZm9PSHlycGFGQ25tNDBLX0FJSmd1UUtqcVFDYlJTX1BuenJ0S1J5TDIzQ0M0a1ljV1ZpaDlTVkdGVlJhTEk2VURPMDVjUWVhbi1pQ1lxalcwdw?oc=5","date":"2024-02-20","type":"deal","source":"BioSpectrum Asia","summary":"Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia - BioSpectrum Asia","headline":"Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPOEdUWXFpdWJEOUZRZkx2WXE5MGhjZ3hDQ1VCZjMtSWtDRzhadGN4Tll0YnJJcUlyUnQ3Nkxyc2k0Ty1YYzI4RDhUMlh6M3NoRC01MDBkekRIZHRTLXo2OHQzaTNwX1pUZjVFX1YwQ25mN2R4WkxmZVdTY1R1V0Zhc0JYOExtNDA2SmxwSC1MSWZIb3hsMXE0?oc=5","date":"2024-02-16","type":"pipeline","source":"BioPharma Dive","summary":"Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies - BioPharma Dive","headline":"Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNMzF5aFplYmQzaVd6OWFrTmRfQlp3MXg2U0NDOXREUHI3NE9VLVZ6WlBzMXIzQ0VzenFTeFE5dmU1bndRUGFjalNRc1BYaDlwR1ZsSUlNdmZMeVNtSnlYNmdIaktXQS1fdVRhVEdvX0ZYLTFaREUtREtoRTlGbHktcW5ZeE9weGpVUlRnOW9Va2ZnOWQ2MHpIM21BYlF6a1dIWTZTbjlqSE9KNVI2dHBkRi1jTjM5X3g0QkRBbUlveXY4S0xq?oc=5","date":"2024-02-16","type":"deal","source":"Contract Pharma","summary":"Xyphos Biosciences & Kelonia Partner to Develop Novel Immuno-Oncology Therapeutics - Contract Pharma","headline":"Xyphos Biosciences & Kelonia Partner to Develop Novel Immuno-Oncology Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNckJOM2ltUS1TNl9ZVzQ0RmVvY1lDajdJQXVjWjJkZW5KZG00UGtfNDNoV3hjSXBJUno0NXZ3T2t0bW4xRDE0QXlRRlhGX0I3aXB4bE9YWWhPalZZVGJXVzc3RklWYWQ4OVpCU0hOb3BLVkNpWG9JbVFsZWdhZDFxa25Gd3FBb29aZzJNdVZja0NNVFJWY2VnUU1KQWJVRlBkU0RFcw?oc=5","date":"2024-02-16","type":"deal","source":"BioSpace","summary":"Astellas Inks Potential $800M Deal with Kelonia for In Vivo Gene Delivery Tech - BioSpace","headline":"Astellas Inks Potential $800M Deal with Kelonia for In Vivo Gene Delivery Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPR3lORjNFRGlUTWFFTDZTeHh5WndBXzFveFlOVWNNejVtclFpWU90TFd3MnBrTGpRQlpsSTFlclZWalZqS05udFJXU2MxOExNSGxLZE5HNGt4c3kxMWlYQ2xSOGFYcGF5Nk9MOUYzM3BJTzUtcl96V1JpaGxxQkdEbWktalRBanJwZUJ1bFJqRERicnUwR015QXRTYWpJZHVjMTd5NXNMZw?oc=5","date":"2024-02-16","type":"deal","source":"BioWorld News","summary":"Astellas’ Xyphos teams with Kelonia on cancer drugs in $800M deal - BioWorld News","headline":"Astellas’ Xyphos teams with Kelonia on cancer drugs in $800M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNRDZkeXFpdml6ZDNKemJnNjgyZmFqb1dsc2lEVU1ZSzY4RnBnU2ZVT0wzSXVxMjNpMUxobmhxVG0wdkczUW5ta2tJWk1oNUxKbTdoY2tWLWU5SGFiVWE3cFE3UGRMQXhUM3pKZDBHcVNrbzU3NHhFNzVDWm1WM2hWclhSVy1uSTNLQjBrRXVuV2liY0tULUJpekVSWEhUek5KSWcxNVVmWEc?oc=5","date":"2024-02-16","type":"pipeline","source":"BioWorld News","summary":"Astellas and Kelonia collaborate on in vivo CAR T-cell therapies - BioWorld News","headline":"Astellas and Kelonia collaborate on in vivo CAR T-cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNMDRybGFwZnBYYVNBUGJfMC1YN1o4TGw1V3JhMXdBRnpyYjJkbjh0VDd6cHQ4bTg2czBoeWRwdFNZVHhrOUZNbkNUTkVwdmhUeVEwVGJkdi1BOG5GMElpVDlvOWsxQ19Fbk1UeGpMU1l2RFd4Y0x5VmdUUzB0ZXVJV0Fwb29OMUFLcldZMk1zV1hkdzZkRUFTWU5kRXB2S01QMVR4Rkp3QVhNbThDZml2bW5tZUcxTVlyVDlQVmNxVVdNT1F0Qm5WRGRWcXZ4a3J4cm9KMnJLbG4wVy1KbHl4OU1HMmJJU1BzN294ZlNPeTl1UE9yZ3Y1em5RcEl0Y2hWelp3NVpPOWE?oc=5","date":"2024-02-15","type":"deal","source":"PR Newswire","summary":"Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics - PR Newswire","headline":"Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutic","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}